Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Increasing Application Of Ai And Machine Learning In Skin Cancer Diagnosis Tools

3. Market Dynamics
3.1. Key Drivers
3.1.1. Increasing Prevalence Of Skin Cancer
3.1.2. Growing Awareness About Skin Cancer Diagnosis & Treatment
3.1.3. Technological Advancements In Skin Cancer Diagnostic Products
3.2. Key Restraints
3.2.1. High Costs Associated With Skin Cancer Treatments
3.2.2. Stringent Regulatory Framework
3.2.3. Lack Of Skilled Medical Professionals

4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Concentration Analysis
4.6. Value Chain Analysis
4.6.1. Research And Development
4.6.2. Manufacturing
4.6.3. Marketing And Sales
4.6.4. Distribution And Logistics
4.6.5. Training And Support

5. Market By Type
5.1. Melanoma
5.2. Non-Melanoma

6. Market By Gender
6.1. Male
6.2. Female

7. Market By Screening Type
7.1. Skin Biopsy
7.2. Dermatoscopy
7.3. Lymph Node
7.4. Biopsy Imaging Tests
7.5. Blood Tests

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. North America Skin Cancer Diagnostics Market Drivers
8.1.3. North America Skin Cancer Diagnostics Market Challenges
8.1.4. Key Players In North America Skin Cancer Diagnostics Market
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.1.1. United States Skin Cancer Diagnostics Market Size & Opportunities
8.1.5.2. Canada
8.1.5.2.1. Canada Skin Cancer Diagnostics Market Size & Opportunities

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Product Launches & Developments
9.1.2. Partnerships & Agreements
9.2. Company Profiles
9.2.1. Amlo Biosciences Limited
9.2.2. Biomerieux Sa
9.2.3. Castle Biosciences Inc
9.2.4. Dermlite Llc
9.2.5. Dermtech Inc
9.2.6. F. Hoffmann-La Roche Ltd
9.2.7. Michelson Diagnostics Ltd
9.2.8. Neracare Gmbh
9.2.9. Skylinedx Bv
9.2.10. Veriskin Inc



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping For North America
Figure 4: Market Concentration Analysis
Figure 5: Value Chain Analysis
Figure 6: North America Skin Cancer Diagnostics Market, Growth Potential, By Type, In 2022
Figure 7: North America Skin Cancer Diagnostics Market, By Melanoma, 2023-2032 (In $ Million)
Figure 8: North America Skin Cancer Diagnostics Market, By Non-Melanoma, 2023-2032 (In $ Million)
Figure 9: North America Skin Cancer Diagnostics Market, Growth Potential, By Gender, In 2022
Figure 10: North America Skin Cancer Diagnostics Market, By Male, 2023-2032 (In $ Million)
Figure 11: North America Skin Cancer Diagnostics Market, By Female, 2023-2032 (In $ Million)
Figure 12: North America Skin Cancer Diagnostics Market, Growth Potential, By Screening Type, In 2022
Figure 13: North America Skin Cancer Diagnostics Market, By Skin Biopsy, 2023-2032 (In $ Million)
Figure 14: North America Skin Cancer Diagnostics Market, By Dermatoscopy, 2023-2032 (In $ Million)
Figure 15: North America Skin Cancer Diagnostics Market, By Lymph Node, 2023-2032 (In $ Million)
Figure 16: North America Skin Cancer Diagnostics Market, By Biopsy Imaging Tests, 2023-2032 (In $ Million)
Figure 17: North America Skin Cancer Diagnostics Market, By Blood Tests, 2023-2032 (In $ Million)
Figure 18: North America Skin Cancer Diagnostics Market, Country Outlook, 2022 & 2032 (In %)
Figure 19: United States Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)
Figure 20: Canada Skin Cancer Diagnostics Market, 2023-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – SKIN CANCER DIAGNOSTICS
TABLE 2: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY GENDER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY GENDER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY SCREENING TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY SCREENING TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: KEY PLAYERS OPERATING IN NORTH AMERICA SKIN CANCER DIAGNOSTICS MARKET
TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS